People
Arcutis, Inc. announced the appointment of Scott Burrows as Vice President, Finance.
Pharma and biotech companies strengthen their executive and leadership teams with new appointments.
With more than 16,000 attendees from 67 countries and hundreds, even thousands of presentations, it can be difficult to get a real grip on everything that went on at the 2019 BIO International Convention held in Philadelphia. Here’s a look at just a few of the highlights.
The report from the state’s Health Policy Commission reveals state spending on prescription drugs nearly doubled from $1.1 billion to $1.9 billion over a five year period.
Hundreds lose their jobs as companies close facilities and shift business focuses.
Thomas Lynch Jr., Bristol-Myers’ chief scientific officer, will leave the company in October. Later-stage development will be managed by Samit Hirawat, the incoming chief medical officer.
The Oregon Bioscience Association recently released a new economic impact report, showing that the state’s biopharma and life science industry is continuing to grow at a significant clip.
Information exposed in the hacking includes financial data, Social Security numbers and medical information, Quest said.
Great Bay Bio announced its formal establishment in Hong Kong and the Chairman, Mr. Kingsley Leung is pleased to appoint Mr. Michael Chan as CEO and co-founder of the company on behalf of the board.
Rentschler Fill Solutions GmbH announced the appointment of Dr. Friedrich Sernetz as Chief Executive Officer (CEO). Dr. Sernetz’ appointment became effective as of June 1, 2019.
PRESS RELEASES